TransDigm Group Incorporated announced it will release its fiscal 2026 fourth quarter earnings before the market opens on November 10, 2026. A conference call to discuss the results will be held at 10:00 a.m. Eastern Time the same day, accessible via registration or live webcast. TransDigm is a major global supplier of engineered aircraft components used in commercial and military aviation, making this earnings report significant for investors tracking aerospace industry performance.
TransDigm's upcoming fiscal 2026 fourth quarter earnings report is scheduled for November 10, 2026. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 02, 2026 19:02 WIB: out of 135 priced US Industrials stocks, 83 rose and 24 fell today. Notable movers include EHang Holdings Ltd (EH) at USD 3.73 with a 3.90% increase, Ryanair Holdings plc (RYAAY) at USD 55.41 up 3.16%, and FuelCell Energy Inc (FCEL) at USD 11.54 rising 2.85%.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
